share_log

Scopus BioPharma | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities

SEC ·  Nov 27, 2021 06:04
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more